Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan H Moore

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
The Cochrane Database of Systematic Reviews|June 18, 2010
Creatine for amyotrophic lateral sclerosis/motor neuron diseaseDaniel M Pastula, Dan H Moore, Richard S Bedlack
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 29, 2009
Insight in ALS: awareness of behavioral change in patients with and without FTDSusan C Woolley, Dan H Moore, Jonathan S Katz
Journal of the American Academy of Dermatology|December 11, 2007
Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996Jeffrey S Schneider, Dan H Moore, Mortimer L Mendelsohn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
Ki-67 correlates with in vivo bromodeoxyuridine labeling index in operable breast cancerWilliam H Goodson, Dan H Moore, Frederick M Waldman
The Cochrane Database of Systematic Reviews|March 16, 2012
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)Robert G Miller, J D Mitchell, Dan H Moore
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 30, 2004
ALSFRS-RPaul H Gordon, Robert G Miller, Dan H Moore
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2003
Geographic excess of estrogen receptor-positive breast cancerChristopher C Benz, Christina A Clarke, Dan H Moore
The Cochrane Database of Systematic Reviews|December 14, 2012
Creatine for amyotrophic lateral sclerosis/motor neuron diseaseDaniel M Pastula, Dan H Moore, Richard S Bedlack
European Journal of Pharmacology|June 20, 2006
AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosisKathline Kim, Dan H Moore, Alexandros Makriyannis, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|April 25, 2007
A comparison of maximal inspiratory pressure and forced vital capacity as potential criteria for initiating non-invasive ventilation in amyotrophic lateral sclerosisMichelle Mendoza, Deborah F Gelinas, Dan H Moore, et al.
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
The Cochrane Database of Systematic Reviews|June 18, 2010
Creatine for amyotrophic lateral sclerosis/motor neuron diseaseDaniel M Pastula, Dan H Moore, Richard S Bedlack
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 29, 2009
Insight in ALS: awareness of behavioral change in patients with and without FTDSusan C Woolley, Dan H Moore, Jonathan S Katz
Journal of the American Academy of Dermatology|December 11, 2007
Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996Jeffrey S Schneider, Dan H Moore, Mortimer L Mendelsohn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
Ki-67 correlates with in vivo bromodeoxyuridine labeling index in operable breast cancerWilliam H Goodson, Dan H Moore, Frederick M Waldman
The Cochrane Database of Systematic Reviews|March 16, 2012
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)Robert G Miller, J D Mitchell, Dan H Moore
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 30, 2004
ALSFRS-RPaul H Gordon, Robert G Miller, Dan H Moore
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2003
Geographic excess of estrogen receptor-positive breast cancerChristopher C Benz, Christina A Clarke, Dan H Moore
The Cochrane Database of Systematic Reviews|December 14, 2012
Creatine for amyotrophic lateral sclerosis/motor neuron diseaseDaniel M Pastula, Dan H Moore, Richard S Bedlack
European Journal of Pharmacology|June 20, 2006
AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosisKathline Kim, Dan H Moore, Alexandros Makriyannis, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|April 25, 2007
A comparison of maximal inspiratory pressure and forced vital capacity as potential criteria for initiating non-invasive ventilation in amyotrophic lateral sclerosisMichelle Mendoza, Deborah F Gelinas, Dan H Moore, et al.
Pageof 11